SHL Stock Overview
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide.
Siemens Healthineers Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||€64.46|
|52 Week High||€67.50|
|52 Week Low||€38.04|
|1 Month Change||12.18%|
|3 Month Change||8.05%|
|1 Year Change||68.19%|
|3 Year Change||67.13%|
|5 Year Change||n/a|
|Change since IPO||113.44%|
Recent News & Updates
Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
|SHL||DE Medical Equipment||DE Market|
Return vs Industry: SHL exceeded the German Medical Equipment industry which returned 58.6% over the past year.
Return vs Market: SHL exceeded the German Market which returned 16% over the past year.
|SHL Average Weekly Movement||3.8%|
|Medical Equipment Industry Average Movement||5.0%|
|Market Average Movement||4.8%|
|10% most volatile stocks in DE Market||9.0%|
|10% least volatile stocks in DE Market||2.5%|
Stable Share Price: SHL is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: SHL's weekly volatility (4%) has been stable over the past year.
About the Company
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.
Siemens Healthineers Fundamentals Summary
|SHL fundamental statistics|
Is SHL overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SHL income statement (TTM)|
|Cost of Revenue||€11.05b|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
Feb 03, 2022
|Earnings per share (EPS)||1.54|
|Net Profit Margin||9.60%|
How did SHL perform over the long term?See historical performance and comparison
1.3%Current Dividend Yield
Does SHL pay a reliable dividends?See SHL dividend history and benchmarks
|Siemens Healthineers dividend dates|
|Ex Dividend Date||Feb 14 2022|
|Dividend Pay Date||Feb 16 2022|
|Days until Ex dividend||75 days|
|Days until Dividend pay date||77 days|
Does SHL pay a reliable dividends?See SHL dividend history and benchmarks
Is Siemens Healthineers undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: SHL (€64.46) is trading below our estimate of fair value (€86.68)
Significantly Below Fair Value: SHL is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: SHL is poor value based on its PE Ratio (41.9x) compared to the German Medical Equipment industry average (28.8x).
PE vs Market: SHL is poor value based on its PE Ratio (41.9x) compared to the German market (20.7x).
Price to Earnings Growth Ratio
PEG Ratio: SHL is poor value based on its PEG Ratio (3x)
Price to Book Ratio
PB vs Industry: SHL's PB Ratio (4.4x) is in line with the DE Medical Equipment industry average.
How is Siemens Healthineers forecast to perform in the next 1 to 3 years based on estimates from 17 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SHL's forecast earnings growth (14.2% per year) is above the savings rate (-0.01%).
Earnings vs Market: SHL's earnings (14.2% per year) are forecast to grow faster than the German market (12.2% per year).
High Growth Earnings: SHL's earnings are forecast to grow, but not significantly.
Revenue vs Market: SHL's revenue (7% per year) is forecast to grow faster than the German market (6% per year).
High Growth Revenue: SHL's revenue (7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SHL's Return on Equity is forecast to be low in 3 years time (15.9%).
How has Siemens Healthineers performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SHL has high quality earnings.
Growing Profit Margin: SHL's current net profit margins (9.6%) are lower than last year (9.8%).
Past Earnings Growth Analysis
Earnings Trend: SHL's earnings have grown by 5.7% per year over the past 5 years.
Accelerating Growth: SHL's earnings growth over the past year (22.4%) exceeds its 5-year average (5.7% per year).
Earnings vs Industry: SHL earnings growth over the past year (22.4%) underperformed the Medical Equipment industry 76.9%.
Return on Equity
High ROE: SHL's Return on Equity (10.7%) is considered low.
How is Siemens Healthineers's financial position?
Financial Position Analysis
Short Term Liabilities: SHL's short term assets (€10.8B) exceed its short term liabilities (€10.1B).
Long Term Liabilities: SHL's short term assets (€10.8B) do not cover its long term liabilities (€15.8B).
Debt to Equity History and Analysis
Debt Level: SHL's net debt to equity ratio (75%) is considered high.
Reducing Debt: SHL's debt to equity ratio has reduced from 398.3% to 83.6% over the past 5 years.
Debt Coverage: SHL's debt is well covered by operating cash flow (21.5%).
Interest Coverage: SHL's interest payments on its debt are well covered by EBIT (51.1x coverage).
What is Siemens Healthineers's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: SHL's dividend (1.32%) is higher than the bottom 25% of dividend payers in the German market (1.01%).
High Dividend: SHL's dividend (1.32%) is low compared to the top 25% of dividend payers in the German market (3.42%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, SHL has been paying a dividend for less than 10 years.
Growing Dividend: SHL's dividend payments have increased, but the company has only paid a dividend for 3 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (50.9%), SHL's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: SHL's dividends in 3 years are forecast to be well covered by earnings (46.9% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Bernd Montag (52 yo)
Dr. Bernhard Montag, also known as Bernd, serves as President and at Chairman of Management Board Siemens at Healthineers AG and has been its Chief Executive Officer and Member of Management Board since 20...
CEO Compensation Analysis
Compensation vs Market: Bernd's total compensation ($USD4.24M) is about average for companies of similar size in the German market ($USD4.56M).
Compensation vs Earnings: Bernd's compensation has been consistent with company performance over the past year.
Experienced Management: SHL's management team is considered experienced (3 years average tenure).
Experienced Board: SHL's board of directors are considered experienced (3.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.8%.
Siemens Healthineers AG's employee growth, exchange listings and data sources
- Name: Siemens Healthineers AG
- Ticker: SHL
- Exchange: XTRA
- Founded: NaN
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: €72.310b
- Shares outstanding: 1.12b
- Website: https://www.siemens-healthineers.com
Number of Employees
- Siemens Healthineers AG
- Henkestrasse 127
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/11/29 23:11|
|End of Day Share Price||2021/11/29 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.